These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2404387)

  • 1. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA.
    Goldberg RK; Kleiman NS; Minor ST; Abukhalil J; Raizner AE
    Am Heart J; 1990 Jan; 119(1):178-84. PubMed ID: 2404387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant results of visual and quantitative estimates of stenosis severity before and after coronary angioplasty.
    Bertrand ME; Lablanche JM; Bauters C; Leroy F; Mac Fadden E
    Cathet Cardiovasc Diagn; 1993 Jan; 28(1):1-6. PubMed ID: 8416326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visual and quantitative evaluation of coronarography findings in patients with percutaneous transluminal coronary angiography].
    Aschermann M; Ferguson JJ
    Vnitr Lek; 1993 Jul; 39(7):645-50. PubMed ID: 8372459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty.
    Sanz ML; Mancini J; LeFree MT; Mickelson JK; Starling MR; Vogel RA; Topol EJ
    Am J Cardiol; 1987 Jul; 60(1):55-60. PubMed ID: 2955693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of angiographic center and local site analysis of PTCA results in a multicenter angioplasty-restenosis trial. The M Heart Group.
    Martinelli MJ; Deutsch E; Ferraro A; Bove AA
    Cathet Cardiovasc Diagn; 1992 Sep; 27(1):8-13. PubMed ID: 1525816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of visual versus central quantitative measurements of angiographic success after percutaneous transluminal coronary angioplasty. NHLBI PTCA Registry Investigators.
    Faxon DP; Vogel R; Yeh W; Holmes DR; Detre K
    Am J Cardiol; 1996 May; 77(12):1067-72. PubMed ID: 8644659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
    Bauters C; Mc Fadden EP; Lablanche JM; Quandalle P; Bertrand ME
    Circulation; 1993 Sep; 88(3):969-74. PubMed ID: 8353924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early luminal deterioration following successful percutaneous transluminal coronary angioplasty. Frequency, prediction and clinical implications.
    Preisack MB; Athanasiadis A; Voelker W; Karsch KR
    Eur Heart J; 1994 Jun; 15(6):739-46. PubMed ID: 8088261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery.
    Zhao XQ; Brown BG; Stewart DK; Hillger LA; Barnhart HX; Kosinski AS; Weintraub WS; King SB
    Circulation; 1996 Jun; 93(11):1954-62. PubMed ID: 8640968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.